You searched for "team"

1383 results found

From Irish innovation to Global impact: Tympany Medical seeks investors

Irish MedTech pioneer Tympany Medical has launched a €600,000 crowdfunding campaign via Crowdcube under the Employment and Investment Incentive Scheme (EIIS), offering a 50% tax rebate for Irish taxpayers. The campaign invites both seasoned and first-time investors to back innovation...

In conversation with Shusheng Gong and Shahed Quraishi on ENT Masterclass<sup>®</sup> China

ENT Masterclass® China was a landmark event that brought an international training resource to Beijing. Profs Shusheng Gong and Shahed Quraishi discuss the organisation of this event, the training pathway in China, and the setup of a typical ENT academic...

From India to Bonnie Scotland

Not many people know that one of the UK’s first cochlear implant surgeons was Raj Singh, OBE, an Indian immigrant whose passions for otology and technology led him to found the Scottish Cochlear Implant Programme, and the Help to Hear...

New treatment for chronic voice disorders

A new regenerative treatment for people with chronic voice disorders has been used in the UK for the first time. Guy’s and St Thomas’ is the first NHS trust in the country to provide this treatment in the larynx (or voice box) for patients with chronic voice conditions that cause voice change or dysphonia, making the voice sound hoarse, strained, breathy, weak, or fluctuate in pitch and loudness.

Trainee-led collaborative research and audit in ENT: where are we now?

In late 2015 INTEGRATE, the UK ENT Trainee Research Network, was formed. Since then, two national projects have been completed and INTEGRATE has grown into a larger, more structured organisation, with otology, head and neck and rhinology subcommittees working alongside...

Aboriginal and Torres Strait Islander ear health in the 2020s

The world is in the midst of a pandemic, and global health is severely threatened by this novel coronavirus which has caused over three million infections of COVID-19 and claimed more than 228,000 lives to date*. Societies and health systems...

2014: Are today’s implantable devices better than conventional solutions for patients with conductive or mixed hearing loss?

Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...

Prolactinomas: when to operate

Prolactinomas are the most common functional pituitary adenomas, comprising 40% of all pituitary adenomas. There are consensus guidelines and several common management pathways. This article discusses the role of surgery for these patients. Following diagnosis, the goals of treatment are...

Outreach to build capacity for surgical ear care in low-resource settings: challenges and opportunities

There are successful models for delivering complex ear surgery where resources may be more limited. Ear, nose and throat conditions are frequently overlooked when global health issues are considered, but hearing loss is the world’s most common sensory deficit, and...

Outreach to build capacity for surgical ear care in low-resource settings: challenges and opportunities

There are successful models for delivering complex ear surgery where resources may be more limited. Ear, nose and throat conditions are frequently overlooked when global health issues are considered, but hearing loss is the world’s most common sensory deficit, and...

To make a difference

Education and training have a key part to play in the development of leaders of the future; Dorte Hammershøi discusses the educational approaches taken in Denmark and the pros and cons of the methods used. Dorte also explains the BEAR...

Harnessing head and neck cancer genomics for personalised medicine

Luc Morris updates us on the future of cancer diagnosis and treatment, which lies in “personalised oncology”, where specific molecular alterations of each tumour will be identified, and matched with actionable alterations in existing therapies, ushering in the era of...